| Peripheral and intestinal regulatory CD4+ CD25high T cells in inflammatory bowel disease J Maul, C Loddenkemper, P Mundt, E Berg, T Giese, A Stallmach, M Zeitz, ... Gastroenterology 128 (7), 1868-1878, 2005 | 840 | 2005 |
| Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans P Bacher, T Hohnstein, E Beerbaum, M Röcker, MG Blango, S Kaufmann, ... Cell 176 (6), 1340-1355. e15, 2019 | 430 | 2019 |
| Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD K Rieger, C Loddenkemper, J Maul, T Fietz, D Wolff, H Terpe, B Steiner, ... Blood 107 (4), 1717-1723, 2006 | 332 | 2006 |
| Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART HJ Epple, C Loddenkemper, D Kunkel, H Tröger, J Maul, V Moos, ... Blood 108 (9), 3072-3078, 2006 | 278 | 2006 |
| Use of intestinal ultrasound to monitor Crohn’s disease activity T Kucharzik, BM Wittig, U Helwig, N Börner, A Rössler, S Rath, C Maaser, ... Clinical Gastroenterology and Hepatology 15 (4), 535-542. e2, 2017 | 247 | 2017 |
| Vedolizumab induction therapy for inflammatory bowel disease in clinical practice–a nationwide consecutive German cohort study DC Baumgart, B Bokemeyer, A Drabik, A Stallmach, S Schreiber, ... Alimentary pharmacology & therapeutics 43 (10), 1090-1102, 2016 | 207 | 2016 |
| The pathogenesis of extraintestinal manifestations: implications for IBD research, diagnosis, and therapy CRH Hedin, SR Vavricka, AJ Stagg, A Schoepfer, T Raine, L Puig, ... Journal of Crohn's and Colitis 13 (5), 541-554, 2019 | 191 | 2019 |
| Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease–a prospective multicenter observational study A Stallmach, C Langbein, R Atreya, T Bruns, A Dignass, K Ende, J Hampe, ... Alimentary pharmacology & therapeutics 44 (11-12), 1199-1212, 2016 | 178 | 2016 |
| Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection S Ben-Horin, M Margalit, P Bossuyt, J Maul, Y Shapira, D Bojic, ... Clinical Gastroenterology and Hepatology 7 (9), 981-987, 2009 | 162 | 2009 |
| Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection S Ben-Horin, M Margalit, P Bossuyt, J Maul, Y Shapira, D Bojic, ... Journal of Crohn's and Colitis 4 (2), 194-198, 2010 | 95 | 2010 |
| Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome M Heindl, N Händel, J Ngeow, J Kionke, C Wittekind, M Kamprad, ... Gastroenterology 142 (5), 1093-1096. e6, 2012 | 83 | 2012 |
| H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy JF Rahier, P Papay, J Salleron, S Sebastian, M Marzo, L Peyrin-Biroulet, ... Gut 60 (4), 456-462, 2011 | 83 | 2011 |
| Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn’s disease: a randomized, double-blind, placebo-controlled study F Beigel, N Teich, S Howaldt, F Lammert, J Maul, S Breiteneicher, C Rust, ... Journal of Crohn's and Colitis 8 (11), 1471-1479, 2014 | 69 | 2014 |
| EndoClot polysaccharide hemostatic system in nonvariceal gastrointestinal bleeding: results of a prospective multicenter observational pilot study JC Preiß, C Barmeyer, N Bürgel, S Daum, HJ Epple, U Günther, J Maul, ... Journal of clinical gastroenterology 50 (10), e95-e100, 2016 | 64 | 2016 |
| Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations J Maul, M Zeitz Langenbeck's archives of surgery 397, 1-10, 2012 | 41 | 2012 |
| Modulation of systemic antigen‐specific immune responses by oral antigen in humans K Kapp, J Maul, A Hostmann, P Mundt, JC Preiss, A Wenzel, A Thiel, ... European journal of immunology 40 (11), 3128-3137, 2010 | 35 | 2010 |
| Pre-study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitis G Fluhr, J Mayerle, E Weber, A Aghdassi, P Simon, T Gress, T Seufferlein, ... BMC gastroenterology 13, 1-6, 2013 | 34 | 2013 |
| Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn’s disease GR Martini, E Tikhonova, E Rosati, MB DeCelie, LK Sievers, F Tran, ... Nature medicine 29 (10), 2602-2614, 2023 | 28 | 2023 |
| Level of tumor necrosis factor production by stimulated blood mononuclear cells can be used to predict response of patients with inflammatory bowel diseases to infliximab B Jessen, Y Rodriguez-Sillke, E Sonnenberg, M Schumann, A Kruglov, ... Clinical Gastroenterology and Hepatology 19 (4), 721-731. e1, 2021 | 27 | 2021 |
| Simultaneous Presence of Non-and Highly Mutated Keyhole Limpet Hemocyanin (KLH)-Specific Plasmablasts Early after Primary KLH Immunization Suggests Cross-Reactive Memory B Cell … C Giesecke, T Meyer, P Durek, J Maul, J Preiß, JFM Jacobs, A Thiel, ... The Journal of Immunology 200 (12), 3981-3992, 2018 | 26 | 2018 |
